Clinical lunch chats
The Triple Threat: Tackling Cardio-Renal-Metabolic Disease in Primary Care
Login/Register now to access the CPD activity!
Cardiovascular-Kidney-Metabolic (CKM) syndrome links heart, kidney, and metabolic health in a dangerous chain reaction. In this episode Dr Theron and Dr Bayat will cover early detection, staging, screening, lifestyle change, and breakthrough therapies like SGLT-2 inhibitors and incretins. Gain practical, evidence-based tools to spot risk sooner, treat smarter, and improve patient outcomes where it matters most, right in your consulting room.
You will learn to:
- Enabling HCPs to define, characterise and assess CKM Syndrome
- What to do in implementing targeted screening and monitoring
- Providing guidance on how to optimise lifestyle and pharmacological interventions in patients
- How to integrate novel and established therapies
- Link treatment to measurable outcomes
Dr Zaheer Bayat
Specialist physician and endocrinologist, Gauteng.
He is the Head of Department of Internal Medicine at Helen Joseph Hospital, a tertiary academic hospital attached to the University of Witwatersrand, Johannesburg, South Africa. He is also a clinician in private practice at the Centre for Integrative Health based in the Sandton Medi-Clinic and the Ahmed Kathrada Private Hospital. Dr Bayat is also part of the Lenasia Clinic Trial and Research Unit (LCTC). Dr Bayat is the immediate past chairperson of SEMDSA and was part of the International Congress of Endocrinology organizing committee in 2018. He is a contributor and part of the editorial panel of the South African Type 2 Diabetes Guidelines as well as the South African Thyroid Guidelines. Dr Bayat is well known locally and internationally, having been an invited speaker and chair to the World Internal Medicine Congress (2018), International Congress of Endocrinology (2018), EASD symposium (2018, 2017) as well as having been part of the Diabetes Education Program in Sub Saharan Africa. He is an invited reviewer to multiple National Internal Medicine and Endocrinology Journals. In addition, Dr Bayat sits on several Regional and National Drug Advisory Boards as well as Diabetes and Thyroid Advisory Panels.
